Suscribirse

Comparative evaluation of oxidative and biochemical parameters of red cell concentrates (RCCs) prepared from G6PD deficient donors and healthy donors during RCC storage - 30/10/24

Doi : 10.1016/j.tracli.2024.08.003 
Samira Moshkelgosha a, Mohammad Reza Deyhim b, , Ramazan Ali Khavari-Nejad a, Mahdieh Meschi c
a Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran 
b Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 
c Department of Biochemistry, Faculty of Biological Science, North Tehran Branch, Islamic Azad University, Tehran, Iran 

Corresponding author at: Assistant Professor of Clinical Biochemistry, Iranian Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, IBTO bldg, Hemmat. Exp.Way. Next to the Milad Tower, P.O.Box: 14665-1157, Tehran, Iran.Assistant Professor of Clinical BiochemistryIranian Blood Transfusion Research CenterHigh Institute for Research and Education in Transfusion MedicineIBTO bldgHemmat. Exp.Way. Next to the Milad TowerP.O.Box: 14665-1157TehranIran

Highlights

Glucose-6-phosphate dehydrogenase (G6PD) as an important antioxidant enzyme in RBC and has a protective effect against oxidative stress.
G6PD deficiency is the most inherited enzyme disorders in red blood cell (RBC) and its lack weakens red blood cells against oxidative stress.
Oxidative damage in red cell concentrates prepared from G6PD deficient donors was more considerable than healthy donors during storage and subsequently, the RBC storage lesion is also higher in G6PD deficient donors than in healthy donors.
Screening of G6PD enzyme deficiency in pandemic area before blood transfusion seems to be necessary and it will help to improve the quality of donated blood in the blood transfusion centers.

El texto completo de este artículo está disponible en PDF.

Abstract

Introduction

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited enzyme disorder in red blood cell (RBC). Due to the importance of G6PD enzyme as an antioxidant in RBC, we tried to investigate the oxidative damage in red cell concentrates (RCCs) prepared from donors with G6PD enzyme deficiency in comparison with healthy donors.

Material method

This cross-sectional study was conducted on 20 male donors. Ten of the donors had G6PD deficiency (as a case) and the others had normal enzyme activity (as a control). Biochemical and oxidative damage parameters were examined in RCCs prepared from two groups on days 0, 7, 14, 21, 28 and 35 of RCCs storage; data comparison was analyzed by SPSS statistical software.

Results

According to the result, lactate concentration increased significantly from the 7th day to the 35th day of RCC storage in G6PD-deficient donors compared to the control (P < 0.05). In addition, malondialdehyde (MDA) concentration in G6PD-deficient RCC showed a significant increase compared to the control in all days of storage (P < 0.05). Among the hematological parameters, mean corpuscular volume (MCV) and mean cell hemoglobin (MCH) increased significantly in all days of RCC storage in G6PD-deficient donors compared to the control (P < 0.05).

Conclusion

Our study showed that oxidative changes in G6PD-deficient donors were significantly increased compared to the healthy donors, which probably leads to RCC storage lesion and an increase in blood transfusion complications. Due to the high prevalence of G6PD enzyme deficiency in pandemic areas, it seems that enzyme screening should be included in donor screening programs.

El texto completo de este artículo está disponible en PDF.

Keywords : G6PD deficiency, Oxidative damage, Red cell concentrate, Red cell storage, Blood transfusion


Esquema


© 2024  Society francophone de transfusion sanguine (SFTS). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 31 - N° 4

P. 201-208 - novembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Anti-A and anti-B titers in A, B and O whole blood donors: Beyond “dangerous O”
  • Amit Kumar Chatterjee, Pandeep Kaur, Davood Bava, Akarshan Gupta, Amit Kumar, Rakesh Kumar
| Artículo siguiente Artículo siguiente
  • Harnessing the potential of blood donors negative for high prevalence Rh antigens: A database initiative for thalassaemia care
  • Akarshan Gupta, Davood Bava, Pandeep Kaur, Amit Kumar Chatterjee, Amit Kumar, Ankita Nigam, Anuneet Tripathi, Rakesh Kumar

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.